English | Español

Regulatory
+ Regulatory
Patient Daily reports | Jan 14, 2025

National health reform group: 'Plenty of evidence that hospitals are not passing along' discounted drug prices under 340b program
+ Regulatory
Patient Daily News Service | Jan 12, 2025

National Consumers League CEO: Federal 340b drug discount program ‘hijacked by hospitals and contract pharmacies’
+ Regulatory
Patient Daily News Service | Dec 15, 2024

Steve Forbes: ‘Unfair’ to allow ‘big insurer-PBMs to pocket big Rx discounts meant for patients’
+ Regulatory
Patient Daily reports | Oct 15, 2024

UnitedHealth, CVS ask FTC commissioners to recuse themselves from active lawsuit
+ Regulatory
Patient Daily | Aug 13, 2024

Patients Come First spokesperson: Medical litigation 'forced many enterprises to shift resources' away from patient care
+ Regulatory
Martin Hoyt | Jul 10, 2024

OPINION: Transparency in Medicare: A Necessity for Public Health Reform
+ Regulatory
Nicholas Malfitano | Jun 11, 2024

U.S. House Energy and Commerce on Oversight and Investigations Subcommittee Chair Griffith on 340B Program: 'it is not mandated to disclose where these dollars actually go and how much is made from the program'
+ Regulatory
Patient Daily | May 31, 2024

US Reps. Bucshon, Carter, Harshbarger introduce legislation for transparency of 340B drug program

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes